Cargando…

Anti-NKG2D single domain-based antibodies for the modulation of anti-tumor immune response

The natural killer group 2 member D (NKG2D) receptor is a C-type lectin-like activating receptor mainly expressed by cytotoxic immune cells including NK, CD8(+) T, γδ T and NKT cells and in some pathological conditions by a subset of CD4(+) T cells. It binds a variety of ligands (NKG2DL) whose expre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raynaud, Adeline, Desrumeaux, Klervi, Vidard, Laurent, Termine, Elise, Baty, Daniel, Chames, Patrick, Vigne, Emmanuelle, Kerfelec, Brigitte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781768/ https://www.ncbi.nlm.nih.gov/pubmed/33457075 http://dx.doi.org/10.1080/2162402X.2020.1854529

Ejemplares similares

State of the Art in Tumor Antigen and Biomarker Discovery
por: Even-Desrumeaux, Klervi, et al.
Publicado: (2011)

Therapeutic Antibodies for the Treatment of Pancreatic Cancer
por: Chames, Patrick, et al.
Publicado: (2010)

Taking up Cancer Immunotherapy Challenges: Bispecific Antibodies, the Path Forward?
por: Del Bano, Joanie, et al.
Publicado: (2015)

A FcγRIII-engaging bispecific antibody expands the range of HER2-expressing breast tumors eligible to antibody therapy
por: Turini, Marc, et al.
Publicado: (2014)

A Bispecific Antibody-Based Approach for Targeting Mesothelin in Triple Negative Breast Cancer
por: Del Bano, Joanie, et al.
Publicado: (2019)

Rapid nanobody-based imaging of mesothelin expressing malignancies compatible with blocking therapeutic antibodies
por: Benloucif, Abdennour, et al.
Publicado: (2023)

Bacterial cytoplasm as an effective cell compartment for producing functional VHH-based affinity reagents and Camelidae IgG-like recombinant antibodies
por: Djender, Selma, et al.
Publicado: (2014)

Selection of Intracellular Single-Domain Antibodies Targeting the HIV-1 Vpr Protein by Cytoplasmic Yeast Two-Hybrid System
por: Matz, Julie, et al.
Publicado: (2014)

4‐1BB and cytokines trigger human NK, γδ T, and CD8(+) T cell proliferation and activation, but are not required for their effector functions
por: Vidard, Laurent
Publicado: (2022)

Straightforward selection of broadly neutralizing single-domain antibodies targeting the conserved CD4 and co-receptor binding sites of HIV-1 gp120
por: Matz, J, et al.
Publicado: (2012)

Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
por: André, Pascale, et al.
Publicado: (2018)

Anti-NKG2D mAb: A New Treatment for Crohn’s Disease?
por: Vadstrup, Kasper, et al.
Publicado: (2017)

An Anti-MICA/B Antibody and IL-15 Rescue Altered NKG2D-Dependent NK Cell Responses in Hepatocellular Carcinoma
por: Mantovani, Stefania, et al.
Publicado: (2020)

Quantitative modeling predicts competitive advantages of a next generation anti‐NKG2A monoclonal antibody over monalizumab for the treatment of cancer
por: Spinosa, Phillip, et al.
Publicado: (2021)

Combining Anti-ERBB3 Antibodies Specific for Domain I and Domain III Enhances the Anti-Tumor Activity over the Individual Monoclonal Antibodies
por: D’Souza, Jimson W., et al.
Publicado: (2014)

Influence of NKG2D Genetic Variants on Response to Anti-TNF Agents in Patients with Rheumatoid Arthritis
por: Iwaszko, Milena, et al.
Publicado: (2018)

Improving the biophysical properties of anti-ricin single-domain antibodies()
por: Turner, Kendrick B., et al.
Publicado: (2015)

VEGFR2 targeted antibody fused with MICA stimulates NKG2D mediated immunosurveillance and exhibits potent anti-tumor activity against breast cancer
por: Wei, Xie, et al.
Publicado: (2016)

New prospects on the NKG2D/NKG2DL system for oncology
por: Ullrich, Evelyn, et al.
Publicado: (2013)

Fusion Proteins of NKG2D/NKG2DL in Cancer Immunotherapy
por: Ding, Hui, et al.
Publicado: (2018)

Astragaloside III Enhances Anti-Tumor Response of NK Cells by Elevating NKG2D and IFN-γ
por: Chen, Xingmeng, et al.
Publicado: (2019)

Targeting NKG2A to boost anti-tumor CD8 T-cell responses in human colorectal cancer
por: Ducoin, Kathleen, et al.
Publicado: (2022)

TCF-1 regulates NKG2D expression on CD8 T cells during anti-tumor responses
por: Harris, Rebecca, et al.
Publicado: (2022)

Improving the Specificity of an Anti-Estradiol Antibody by Random Mutagenesis and Phage Display
por: Coulon, S., et al.
Publicado: (2000)

The Role and Regulation of the NKG2D/NKG2D Ligand System in Cancer
por: Tan, Ge, et al.
Publicado: (2023)

Lymphoma and Myeloma Cell Resistance to Cytotoxic Agents and Ionizing Radiations Is Not Affected by Exposure to Anti–IL-6 Antibody
por: Gougelet, Angélique, et al.
Publicado: (2009)

Tremor Associated with Chronic Inflammatory Demyelinating Polyneuropathy and Anti‐Neurofascin‐155 Antibodies
por: Bailly, Laurent, et al.
Publicado: (2018)

Selection and Characterization of Anti-Dengue NS1 Single Domain Antibodies
por: Shriver-Lake, Lisa C., et al.
Publicado: (2018)

NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
por: Frazao, Alexandra, et al.
Publicado: (2019)

Cervical cancer cell lines expressing NKG2D-ligands are able to down-modulate the NKG2D receptor on NKL cells with functional implications
por: Jimenez-Perez, Miriam I, et al.
Publicado: (2012)

Intratumoral co‐injection of NK cells and NKG2A‐neutralizing monoclonal antibodies
por: Melero, Ignacio, et al.
Publicado: (2023)

Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A
por: Mahaweni, Niken M., et al.
Publicado: (2018)

Targeting NKG2DL with Bispecific NKG2D–CD16 and NKG2D–CD3 Fusion Proteins on Triple–Negative Breast Cancer
por: Kaidun, Polina, et al.
Publicado: (2023)

Novel single-domain antibodies against the EGFR domain III epitope exhibit the anti-tumor effect
por: Chen, Tao, et al.
Publicado: (2020)

Genetic Fusion of an Anti-BclA Single-Domain Antibody with Beta Galactosidase
por: Anderson, George P., et al.
Publicado: (2018)

Domain binding and isotype dictate the activity of anti-human OX40 antibodies
por: Griffiths, Jordana, et al.
Publicado: (2020)

Discovery of Anti-PD-L1 Human Domain Antibodies for Cancer Immunotherapy
por: Liu, Hao, et al.
Publicado: (2022)

Stabilization of a Broadly Neutralizing Anti-Chikungunya Virus Single Domain Antibody
por: Liu, Jinny L., et al.
Publicado: (2021)

Structure and specificity of an anti‐chloramphenicol single domain antibody for detection of amphenicol residues
por: Swofford, Charles A., et al.
Publicado: (2022)

STING-dependent cytosolic DNA sensor pathways regulate NKG2D ligand expression
por: Le Bert, Nina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_arsojrs04g07vjeg3v5j0spp8b